MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 50 filers reported holding MILESTONE PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 4.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,455,821 | +34.2% | 1,102,895 | +82.0% | 1.04% | +45.3% |
| Q1 2024 | $1,085,000 | +46.9% | 606,145 | +37.0% | 0.72% | +27.7% |
| Q4 2023 | $738,728 | -12.6% | 442,352 | +62.3% | 0.56% | -27.8% |
| Q3 2023 | $844,750 | +8.8% | 272,500 | 0.0% | 0.78% | +11.0% |
| Q2 2023 | $776,625 | -10.4% | 272,500 | +23.9% | 0.70% | -6.7% |
| Q1 2023 | $866,800 | +21.6% | 220,000 | +22.2% | 0.75% | +10.0% |
| Q4 2022 | $712,800 | – | 180,000 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 2,340,207 | $3,089,073 | 5.63% |
| Stonepine Capital Management, LLC | 1,239,199 | $1,635,743 | 1.50% |
| Alta Fundamental Advisers LLC | 2,658,589 | $3,509,337 | 1.11% |
| BML Capital Management, LLC | 1,102,895 | $1,455,821 | 1.04% |
| Altium Capital Management LP | 1,012,368 | $1,336,326 | 0.54% |
| Bleichroeder LP | 1,326,085 | $1,750,432 | 0.52% |
| Nantahala Capital Management | 1,750,000 | $2,310,000 | 0.14% |
| Ikarian Capital, LLC | 466,019 | $619,806 | 0.11% |
| RTW INVESTMENTS, LP | 3,256,102 | $4,298,055 | 0.07% |
| Orbimed Advisors | 2,000,000 | $2,640,000 | 0.05% |